tiprankstipranks
CureVac files to sell $200M of common stock
The Fly

CureVac files to sell $200M of common stock

Goldman Sachs & Co. LLC, Jefferies LLC, and SVB Securities LLC are acting as bookrunners for the proposed offering. Van Lanschot Kempen is acting as lead manager for the proposed offering.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on CVAC:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles